Literature DB >> 23534874

Intraoperative radiotherapy of early breast cancer using low-kilovoltage x-rays-reasons for omission of planned intraoperative irradiation.

Benjamin Tuschy1, Sebastian Berlit, Christiane Nasterlack, Karin Tomé, Elena Blank, Frederik Wenz, Marc Sütterlin.   

Abstract

The purpose of this study is to investigate reasons for omission of a planned intraoperative radiotherapy (IORT) during breast-conserving surgery (BCS). Between 2002 and 2009, in 297 women an IORT during BCS was planned. In 55 women this irradiation was finally not performed. We retrospectively analyzed pre-, peri-, and postoperative data of these 55 women. Main reasons for omission of an IORT were insufficient tumor-skin distance (n = 20, 35.1%), an oversized wound cavity (n = 14, 24.6%), and a combination of both (n = 8, 14%). Further reasons (n = 12, 21.1%) were temporal shortage, unplanned maintenance work of the Intrabeam(®) device, unsuitable anatomicosurgical conditions, and ineligible histologic findings. Apart from suitable anatomic conditions, a precise preoperative ultrasonography as well as a strict interdisciplinary preoperative management is important for successful application of IORT.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23534874     DOI: 10.1111/tbj.12103

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  3 in total

Review 1.  Intraoperative radiotherapy for breast cancer.

Authors:  Norman R Williams; Katharine H Pigott; Chris Brew-Graves; Mohammed R S Keshtgar
Journal:  Gland Surg       Date:  2014-05

Review 2.  Accelerated partial breast irradiation with brachytherapy: patient selection and technique considerations.

Authors:  Daniel M Trifiletti; Kara D Romano; Shayna L Showalter; Kelli A Reardon; Bruce Libby; Timothy N Showalter
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-07-29

3.  A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer.

Authors:  Elena Sperk; Daniela Astor; Anke Keller; Grit Welzel; Axel Gerhardt; Benjamin Tuschy; Marc Sütterlin; Frederik Wenz
Journal:  Radiat Oncol       Date:  2014-07-12       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.